Mark Pruzanski

Insider Reports History

Entity
Individual
Location
C/O Intercept Pharmaceuticals, Inc., 18 Desbrosses St., New York, NY
Signature
/s/ Jason A. Keyes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Pruzanski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Equillium, Inc. Director Stock Option (right to buy) 20K May 22, 2024 Direct
Equillium, Inc. Director Director Stock Option (right to buy) 0 Feb 14, 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Mark Pruzanski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EQ Equillium, Inc. Feb 14, 2025 8 $0 4 Feb 19, 2025 Director
EQ Equillium, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 14 -$11.8M 4 Nov 13, 2023 Director
EQ Equillium, Inc. May 22, 2023 1 $0 4 May 23, 2023 Director
EQ Equillium, Inc. May 24, 2022 1 $0 4 May 25, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 30, 2021 2 $39.9K 4 Dec 2, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Oct 29, 2021 2 $39.1K 4 Nov 2, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 30, 2021 2 $34.5K 4 Oct 4, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Aug 31, 2021 2 $34.6K 4 Sep 1, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Jul 30, 2021 2 $40.1K 4 Aug 2, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 30, 2021 2 $46.3K 4 Jul 1, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 28, 2021 2 $38.6K 4 Jun 2, 2021 Director
EQ Equillium, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director